title: Functional improvement of mutant keratin cells on addition of desmin: an alternative approach to gene therapy for dominant diseases.
abstract: A major challenge to the concept of gene therapy for dominant disorders is the silencing or repairing of the mutant allele. Supplementation therapy is an alternative approach that aims to bypass the defective gene by inducing the expression of another gene, with similar function but not susceptible to the disrupting effect of the mutant one. Epidermolysis bullosa simplex (EBS) is a genetic skin fragility disorder caused by mutations in the genes for keratins K5 or K14, the intermediate filaments present in the basal cells of the epidermis. Keratin diseases are nearly all dominant in their inheritance. In cultured keratinocytes, mutant keratin renders cells more sensitive to a variety of stress stimuli such as osmotic shock, heat shock or scratch wounding. Using a 'severe' disease cell culture model system, we demonstrate reversion towards wild-type responses to stress after transfection with human desmin, an intermediate filament protein normally expressed in muscle cells. Such a supplementation therapy approach could be widely applicable to patients with related individual mutations and would avoid some of the financial obstacles to gene therapy for rare diseases.
authors.affiliation: Cancer Research UK Cell Structure Research Group, School of Life Sciences, University of Dundee, MSI/WTB Complex, Dundee, Scotland, UK.
authors.forename: M
authors.initials: M
authors.lastname: D'Alessandro
authors.forename: S M
authors.initials: SM
authors.lastname: Morley
authors.forename: P H
authors.initials: PH
authors.lastname: Ogden
authors.forename: M
authors.initials: M
authors.lastname: Liovic
authors.forename: R M
authors.initials: RM
authors.lastname: Porter
authors.forename: E B
authors.initials: EB
authors.lastname: Lane
mesh_terms: D002465:Cell Movement / Q000502:physiology; D002478:Cells, Cultured; D003599:Cytoskeleton / Q000502:physiology; D003893:Desmin / Q000235:genetics*; D016110:Epidermolysis Bullosa Simplex / Q000235:genetics / Q000628:therapy*; D005799:Genes, Dominant / Q000235:genetics; D015316:Genetic Therapy / Q000379:methods*; D006358:Hot Temperature; D006801:Humans; D053547:Keratin-14; D053555:Keratin-5; D015603:Keratinocytes / Q000502:physiology*; D007633:Keratins / Q000235:genetics*; D018482:Muscle, Skeletal / Q000503:physiopathology; D009154:Mutation; D009995:Osmosis / Q000502:physiology; D014162:Transfection; D014945:Wound Healing / Q000235:genetics
chemical_list: D003893:Desmin; C507540:KRT14 protein, human; C503940:KRT5 protein, human; D053547:Keratin-14; D053555:Keratin-5; D007633:Keratins